Ezetimibe/Simvastatin Is More Effective Than Atorvastatin In Metabolic Syndrome
New data indicate that patients with metabolic syndrome have a greater likelihood of reaching specified lipid and high-sensitivity C-reactive protein (hs-CRP) levels if they are treated with ezetimibe/simvastatin than with atorvastatin. The findings were announced at the 46th European Association for the Study of Diabetes (EASD) meeting…
Related Blogs
- High Dosages Of Zocor (Simvastatin) Increases The Risk Of Muscle …
- Ron Coleman's LIKELIHOOD OF CONFUSION® | Creative license
- Ron Coleman's LIKELIHOOD OF CONFUSION® | Sounds original!
- Damien Hirst x Converse (PRODUCT)RED Chuck Taylor All Star Sneaker …
- Homemade dog recipes » European Food
- ObamaCare: the good news just keeps on coming [Darleen Click]
- What will they say?…(The Sanity Inspector) – protein wisdom
- “Poll: 71% of Republican voters back tea party” [JHoward]
- “Dems retreat to coasts as GOP rules vast interior” [JHoward
- Risk Factors Or Likelihood of Having Colon Cancer

















